CPH — Cipher Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- CA$372.17m
- CA$391.96m
- $33.36m
- 85
- 50
- 78
- 82
Annual balance sheet for Cipher Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9.14 | 20.5 | 28.8 | 39.8 | 17.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9.22 | 6.66 | 6.8 | 5.09 | 13.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 20.1 | 29.3 | 38.2 | 48.3 | 38.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.91 | 0.501 | 0.481 | 0.402 | 0.68 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 44.3 | 51.7 | 73.8 | 86 | 163 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.92 | 12.3 | 9.37 | 5.25 | 19.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.6 | 12.8 | 9.7 | 5.51 | 60.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 32.6 | 38.9 | 64.1 | 80.5 | 102 |
| Total Liabilities & Shareholders' Equity | 44.3 | 51.7 | 73.8 | 86 | 163 |
| Total Common Shares Outstanding |